Off-the-shelf CAR natural killer progenitor cell therapies are built to last
Cell Stem Cell · 2026
DOI: 10.1016/j.stem.2026.02.004 ↗Kurz gefasst
Kommentar in der Zeitschrift Cell Stem Cell, 2026. Verfasst von Noor Radde und 1 weiteren Autor:innen. Beteiligte Einrichtung: Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02114, USA; Cellular Immunotherapy Program, Massachusetts Genera…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Receptors, Chimeric Antigen, Induced Pluripotent Stem Cells, Immunotherapy, Adoptive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Induced pluripotent stem cell (iPSC)-derived chimeric antigen receptor (CAR) natural killer (NK) cells are an emerging class of off-the-shelf cellular immunotherapy limited by short-term persistence. Wang et al.1 develop a platform for lineage-committed progenitor cell therapy to sustain in vivo CAR iNK cell lymphopoiesis and enhance tumor control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02114, USA; Cellular Immunotherapy Program, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA…
Förderung
- NCI NIH HHS
Zitieren
APA
Radde, N., & Jan, M. (2026). Off-the-shelf CAR natural killer progenitor cell therapies are built to last. Cell Stem Cell. https://doi.org/10.1016/j.stem.2026.02.004
Vancouver
Radde N, Jan M. Off-the-shelf CAR natural killer progenitor cell therapies are built to last. Cell Stem Cell. 2026. doi:10.1016/j.stem.2026.02.004
BibTeX
@article{Radde2026,
author = {Radde, Noor and Jan, Max},
title = {Off-the-shelf CAR natural killer progenitor cell therapies are built to last},
journal = {Cell Stem Cell},
year = {2026},
doi = {10.1016/j.stem.2026.02.004}
}
EUVIMED